Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On Post author:Sam Post published:November 15, 2017 Post category:BioPharma Teva’s stock jumped as investors get more hopeful about the future. Source: BioSpace You Might Also Like Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed June 26, 2017 FDA Lashes Out at Jazz Pharma CMO for Continued Regulatory Violations January 26, 2017 Mylan Launches Generic Gleevec Tablets October 1, 2017
Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed June 26, 2017
